• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to: On meta-analytic models and the effect of hydroxychloroquine use in COVID-19.

作者信息

Schmitt Andreas M, Axfors Cathrine, Moher David, Goodman Steven N, Ioannidis John P A, Hemkens Lars G

机构信息

Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.

Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.

出版信息

Nat Commun. 2025 Jul 11;16(1):6354. doi: 10.1038/s41467-025-60479-w.

DOI:10.1038/s41467-025-60479-w
PMID:40645955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12254396/
Abstract
摘要

相似文献

1
Reply to: On meta-analytic models and the effect of hydroxychloroquine use in COVID-19.回复：关于荟萃分析模型及羟氯喹在COVID-19治疗中的作用
Nat Commun. 2025 Jul 11;16(1):6354. doi: 10.1038/s41467-025-60479-w.
2
Comprehensive analysis of gastrointestinal side effects in COVID-19 patients undergoing combined pharmacological treatment with azithromycin and hydroxychloroquine: a systematic review and network meta-analysis.综合分析 COVID-19 患者联合使用阿奇霉素和羟氯喹进行药物治疗的胃肠道副作用：系统评价和网络荟萃分析。
Crit Rev Toxicol. 2024 Jul;54(6):345-358. doi: 10.1080/10408444.2024.2348169. Epub 2024 Jun 11.
3
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
4
Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials.COVID-19 住院患者中阿奇霉素和羟氯喹的疗效：随机对照试验的网络荟萃分析。
J Med Virol. 2021 Dec;93(12):6737-6749. doi: 10.1002/jmv.27259. Epub 2021 Aug 17.
5
The PRINCIPLE randomised controlled open label platform trial of hydroxychloroquine for treating COVID19 in community based patients at high risk.羟氯喹治疗社区高危COVID-19患者的主要随机对照开放标签平台试验。
Sci Rep. 2025 Jul 4;15(1):23850. doi: 10.1038/s41598-025-09275-6.
6
Prevalence of increased alcohol use and alcohol use disorders in adult victims of terrorist attacks: a systematic and meta-analytic review.恐怖袭击成年受害者中酒精使用增加和酒精使用障碍的流行率：系统评价和荟萃分析。
Am J Drug Alcohol Abuse. 2023 Nov 2;49(6):705-722. doi: 10.1080/00952990.2023.2275526. Epub 2023 Dec 11.
7
The Effect of Hormonal Contraceptive Use on Skeletal Muscle Hypertrophy, Power and Strength Adaptations to Resistance Exercise Training: A Systematic Review and Multilevel Meta-analysis.激素避孕对抵抗运动训练引起的骨骼肌肥大、力量和强度适应性的影响：系统评价和多层次荟萃分析。
Sports Med. 2024 Jan;54(1):105-125. doi: 10.1007/s40279-023-01911-3. Epub 2023 Sep 27.
8
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.药物干预治疗 COVID-19 的疗效和安全性比较：系统评价和网络荟萃分析。
PLoS Med. 2020 Dec 30;17(12):e1003501. doi: 10.1371/journal.pmed.1003501. eCollection 2020 Dec.
9
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.阿司匹林用于心血管疾病和癌症一级预防的预防性使用：系统评价和综述概述。
Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430.
10
The impact of influenza and pneumococcal vaccination on antibiotic use: an updated systematic review and meta-analysis.流感和肺炎球菌疫苗接种对抗生素使用的影响：更新的系统评价和荟萃分析。
Antimicrob Resist Infect Control. 2023 Jul 14;12(1):70. doi: 10.1186/s13756-023-01272-6.

本文引用的文献

1
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.作者更正：来自一项随机试验国际协作荟萃分析的新冠病毒病中羟氯喹和氯喹的死亡率结果
Nat Commun. 2024 Feb 5;15(1):1075. doi: 10.1038/s41467-024-45360-6.
2
Impact of Allocation Concealment and Blinding in Trials Addressing Treatments for COVID-19: A Methods Study.评估 COVID-19 治疗方法的试验中分配隐藏和盲法的影响：一项方法学研究。
Am J Epidemiol. 2023 Oct 10;192(10):1678-1687. doi: 10.1093/aje/kwad131.
3
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.REMAP-CAP 随机临床试验中 COVID-19 危重症患者的长期（180 天）结局。
JAMA. 2023 Jan 3;329(1):39-51. doi: 10.1001/jama.2022.23257.
4
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.瑞德西韦和其他三种药物治疗 COVID-19 住院患者：世卫组织团结随机试验的最终结果和更新的荟萃分析。
Lancet. 2022 May 21;399(10339):1941-1953. doi: 10.1016/S0140-6736(22)00519-0. Epub 2022 May 2.
5
Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE - Coalition V): A double-blind, multicentre, randomised, controlled trial.羟氯喹啉与安慰剂治疗非住院COVID-19患者的疗效比较（COPE - 联盟V）：一项双盲、多中心、随机对照试验。
Lancet Reg Health Am. 2022 Jul;11:100243. doi: 10.1016/j.lana.2022.100243. Epub 2022 Mar 31.
6
How to Use and Interpret the Results of a Platform Trial: Users' Guide to the Medical Literature.如何使用和解释平台试验的结果：医学文献用户指南。
JAMA. 2022 Jan 4;327(1):67-74. doi: 10.1001/jama.2021.22507.
7
Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials.羟氯喹和 COVID-19 患者的死亡率：观察性研究和随机对照试验的系统评价和荟萃分析。
Pathog Glob Health. 2021 Oct-Dec;115(7-8):456-466. doi: 10.1080/20477724.2021.1936818. Epub 2021 Jun 15.
8
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.羟氯喹和氯喹治疗 COVID-19 的国际合作随机试验荟萃分析的死亡率结果。
Nat Commun. 2021 Apr 15;12(1):2349. doi: 10.1038/s41467-021-22446-z.
9
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
10
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.